002044 Meinian Onehealth Healthcare Holdings
- 4.22
- -0.09-2.09%
Meinian Onehealth Healthcare Holdings News
American Health (002044): In-depth commercial insurance layout highlights the value of data resources
American Health (002044): Outstanding performance in Q3, innovative business continues to be empowered
Mei Nian Health (002044) Company Dynamic Research: Double increase in revenue and profit in the third quarter released “Health Xiaomei”, the first AI digital intelligent health manager in China
American Health (002044): The share of individual examinations and customer unit prices is steadily increasing, and leading medical examinations are leading the upgrade of digital intelligent health management
American Health (002044): The company's revenue is growing positively in 2024Q2, and the share of customer unit prices and individual inspection revenue continues to rise
American Health (002044): The sharp rise in volume and price is in line with expectations, and growth can be expected
American Health (002044): Results quickly resumed in 2023, and the volume and price of the medical examination business rose sharply
American Health (002044): 2023 results are in line with expectations 2024Q1, facing a high base revenue decline, profitability remains steady
American Health (002044): The annual business trend is improving, and data assets have begun to be included in the table
American Health (002044): The trend of increasing customer unit prices in 2023 is evident, and performance is growing strongly
American Health (002044): The trend of increasing customer unit prices in 2023 is evident, and performance is growing strongly
American Health (002044): 2023 results are in line with market expectations, profit side turned loss into profit
American Health (002044): Performance is in line with expectations, the medical examination industry continues to expand, and performance volume and price rise sharply
American Health (002044): Strong rise in volume and price, leading performance growth, development prospects can be expected
Guojin Securities released a research report on April 25 stating that it gave American Health (002044.SZ) a purchase rating. The main reasons for the rating include: 1) the four major brands are developing collaboratively, increasing volume and price to p
American Health (002044): Performance forecasts meet expectations, leading private medical examinations embark on a new journey
American Health (002044) performance forecast review: Excellent performance in the fourth quarter and continued to increase innovative products and AI applications
American Health (002044): Revenue exceeded expectations, medical examination demand recovered as scheduled
MeiNian Health (002044): Equity incentives implemented, performance targets highlight high growth confidence
Research Report Nuggets: Guohai Securities: Maintaining the “buy” rating of American Health, optimistic about the value of the company's preventive medicine platform in the medium to long term
No Data
